A systematic review of PET and PET/CT in oncology: a way to personalize cancer treatment in a cost-effective manner?
about
PET/CT imaging in lung cancer: indications and findingsClinical molecular imaging with radiotracers: current statusRapid development of image analysis research tools: Bridging the gap between researcher and clinician with pyOsiriX.(18)F-FDG/PET May Help to Identify a Subgroup of Patients with T1-T2 Breast Cancer and 1-3 Positive Lymph Nodes Who Are at a High Risk of Recurrence after MastectomyPET/CT versus body coil PET/MRI: how low can you go?Cost-effectiveness of Fluorine-18-Fluorodeoxyglucose positron emission tomography in tumours other than lung cancer: A systematic review.[¹⁸F]fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography imaging in oncology: initial staging and evaluation of cancer therapyFunctional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance.Diagnostic value of using 18F-FDG PET and PET/CT in immunocompetent patients with primary central nervous system lymphoma: A systematic review and meta-analysis.Lymphoma: current status of clinical and preclinical imaging with radiolabeled antibodies.Response to trastuzumab by HER2 expressing breast tumour xenografts is accompanied by decreased Hexokinase II, glut1 and [18F]-FDG incorporation and changes in 31P-NMR-detectable phosphomonoesters.PET imaging of CXCR4 receptors in cancer by a new optimized ligand.Expression of VEGF and MMP-9 and MRI imaging changes in cerebral glioma.Added value of cost-utility analysis in simple diagnostic studies of accuracy: (18)F-fluoromethylcholine PET/CT in prostate cancer staging.The role of positron emission tomography in the diagnosis, staging and response assessment of non-small cell lung cancer.Functionally Oriented Tumor Microenvironment Responsive Polymeric Nanoassembly: Engineering and Applications
P2860
Q26801449-DE0A4F1C-3CED-4B9A-BF88-C54641EA2280Q26994741-DAA0514B-3826-42C5-87E2-72704F29FEE3Q27317305-F50B16A3-54E7-450F-9DAA-F68B1E02D25FQ36832255-2E7B2CB9-107E-4658-B94A-33B6D58E8DB4Q37064366-B30EBE95-356A-4BDC-87A7-AC0B40CF20EBQ37702368-AD71F615-D83E-4264-B214-E4F39486C54CQ38077874-01CF9688-FE9F-4102-8F47-5AC002D9BF06Q38095361-5CBEDFDF-ACBB-4BBE-AE21-493334A45B5EQ38780459-A7031615-1900-4544-A684-7B79277C5E0BQ38795442-907918E6-5CAA-470C-A4C0-685BE3C66D44Q39239280-4DC5F7AE-47C3-44C6-A754-F7B3EB6B0686Q39502623-C1DBD63E-E7CA-4E58-BA37-BAF6F75BEFC7Q39577067-602CD42E-9D38-4D29-9CA5-3F89E73DB922Q39607551-418BE463-A1FF-43C1-BE65-DAC81740098FQ55221692-C801CDF5-4A7B-4971-A314-1C558182E665Q57355217-B55E7684-2094-402D-9F85-B84527395F78
P2860
A systematic review of PET and PET/CT in oncology: a way to personalize cancer treatment in a cost-effective manner?
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A systematic review of PET and ...... nt in a cost-effective manner?
@ast
A systematic review of PET and ...... nt in a cost-effective manner?
@en
type
label
A systematic review of PET and ...... nt in a cost-effective manner?
@ast
A systematic review of PET and ...... nt in a cost-effective manner?
@en
prefLabel
A systematic review of PET and ...... nt in a cost-effective manner?
@ast
A systematic review of PET and ...... nt in a cost-effective manner?
@en
P2860
P31
P356
P1476
A systematic review of PET and ...... nt in a cost-effective manner?
@en
P2093
Astrid Langer
P2860
P2888
P356
10.1186/1472-6963-10-283
P5008
P577
2010-10-08T00:00:00Z
P5875
P6179
1024011864